Chemistry:5-MeO-DsBT

From HandWiki

5-MeO-DsBT, also known as 5-methoxy-N,N-di-sec-butyltryptamine, is a chemical compound and possible psychedelic drug of the tryptamine and 5-methoxytryptamine families related to 5-MeO-DMT.[1] It was briefly mentioned by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved).[1] He described it as being an unknown compound.[1] Relatedly, its route, dose, and duration were not described.[1] 5-MeO-DsBT was first described in the literature by Shulgin in TiHKAL in 1997.[1] It is a skeletal isomer of 5-MeO-DBT.[1] Subsequently, close analogues of 5-MeO-DsBT like 5-MeO-MsBT and 5-MeO-NsBT emerged as novel designer drugs in the early 2020s.[2][3][4] 5-MeO-DsBT is not a controlled substance in Canada as of 2025.[5]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252. http://www.erowid.org/library/books_online/tihkal/tihkal.shtml. 
  2. ↑ "5-MeO-MsBT (5-methoxy-N-methyl-N-secbutyltryptamine)" (in ru). https://aipsin.com/newsubstance/987/. 
  3. ↑ "5-MeO-NsBT (5-MeO-N-secbutyltryptamine)" (in ru). https://aipsin.com/newsubstance/986/. 
  4. ↑ "Recent trends in the identification of psychoactive substances." (in ru). AIPSIN Belarusian Monitoring Platform (37). January 2023. doi:10.13140/RG.2.2.34396.46722. https://www.researchgate.net/doi/10.13140/RG.2.2.34396.46722. Retrieved 2 January 2026. 
  5. ↑ "Controlled Drugs and Substances Act". https://laws-lois.justice.gc.ca/eng/acts/c-38.8/FullText.html. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:5-MeO-DsBT&oldid=4245745"